Shares of CanniMed Therapeutics Inc. (TSE:CMED – Get Free Report) fell 5.3% during trading on Monday . The company traded as low as C$27.00 and last traded at C$27.00. 52,208 shares were traded during trading, a decline of 87% from the average session volume of 387,394 shares. The stock had previously closed at C$28.50.
CanniMed Therapeutics Trading Down 5.3 %
The business’s fifty day moving average is C$27.00.
CanniMed Therapeutics Company Profile
CanniMed Therapeutics Inc operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills.
Recommended Stories
- Five stocks we like better than CanniMed Therapeutics
- Top Stocks Investing in 5G Technology
- Survey: Top 175 Fittest Retirement Locations in America
- What is Insider Trading? What You Can Learn from Insider Trading
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- What is Short Interest? How to Use It
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for CanniMed Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanniMed Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.